描述
Materials and methods illustration showing experimental protocols for prostate cancer cell transfection with siRNAs targeting SIRT1 or MTNR1A (MT1), and CCK-8 cell proliferation assay procedures.
Figure 28
Source Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 28: Materials and methods illustration showing experimental protocols for prostate cancer cell transfection with siRNAs targeting SIRT1 or MTNR1A (MT1), and CCK-8 cell proliferation assay procedures.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Materials and methods illustration showing experimental protocols for prostate cancer cell transfection with siRNAs targeting SIRT1 or MTNR1A (MT1), and CCK-8 cell proliferation assay procedures." /> <figcaption>Figure 28. Materials and methods illustration showing experimental protocols for prostate cancer cell transfection with siRNAs targeting SIRT1 or MTNR1A (MT1), and CCK-8 cell proliferation assay procedures.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>